Jubilant Life Sciences Ltd  

(Public, BOM:530019)   Watch this stock  
Find more results for 530019
153.80
-2.00 (-1.28%)
May 21 - Close
BOM real-time data - Disclaimer
Currency in INR
Range 151.55 - 157.80
52 week 151.55 - 248.25
Open 156.00
Vol. 15,177.00
Mkt cap 24.50B
P/E 16.02
Div/yield 3.00/1.95
EPS 9.60
Shares 159.28M
Beta     -
Inst. own     -
Jul 22, 2013
Q1 2014 Jubilant Life Sciences Ltd Earnings Release Add to calendar
  

Key stats and ratios

Q1 (Mar '13) 2013
Net profit margin -1.75% 3.65%
Operating margin 1.32% 6.59%
EBITD margin - 20.37%
Return on average assets - 2.33%
Return on average equity - 6.43%
Employees 5,763 -
Carbon Disclosure Rating - -

Address

1A, Sector 16A
NOIDA, 201301
India
+91-120-4361000 (Phone)
+91-120-4234881 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

Jubilant Life Sciences Limited is a global pharmaceutical and life sciences player engaged in manufacture and supply of active pharmaceutical ingredients (APIs), generics and life science ingredients. It is focused on production of APIs for cardiovascular system (CVS) and central nervous system (CNS) therapeutic areas besides anti-infective and anti-ulcerants. Specialty Pharmaceuticals business focuses on radiopharmaceuticals and allergy therapy products segments. It also undertakes the development, manufacture and distribution of human allergen extracts for pollen, environmental, venom, mites, mold and food. It follows a partnership approach to contract manufacturing of sterile injectables and non-sterile products consisting of ointment, cream and liquids. It operates hospitals each at Baharampur and at Barasat. Its life science ingredients business includes revenue lines of products and exclusive synthesis, nutritional ingredients and life science chemicals segments.

Officers and directors

Shyam Sunder Bhartia Executive Chairman of the Board, Managing Director
Age: 60
Hari Shanker Bhartia Executive Co-Chairman of the Board, Managing Director
Age: 55
R. Sankaraiah Executive Director - Finance
Age: 53
Neeraj Agrawal Chief Executive Officer - Generics
Age: 39
Subir Kumar Basak President - Jubilant Drug Discovery Services (Jubilant Biosys & Jubilant Chemsys)
Martyn Coombs President - Jubilant DraxImage
Scott Delaney Chief Executive Officer of Jubilant Cadista
Kevin Garrity President - Allergy Business
Marcelo Morales Chief Executive Officer - Contract Manufacturing & Services of Jubilant HollisterStier
Goutam Muhuri President - R&D Dosage Forms
Age: 53